SEP 19, 2019 8:00 AM PDT

Importance and Role of Biomarkers in the Management of Pediatric Inflammatory Disease

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Attending Physician, Pediatric Gastroenterology, Hepatology and Nutrition Co-Lead Investigator, Gi Care for Kids Site for ImproveCareNow, Quality Improvement Collaborative
    Biography
      Benjamin D. Gold, MD, joined Children's Center for Digestive Healthcare, LLC. GI Care for Kids, LLC. in 2009. Prior to joining CCDHC, Dr. Gold had an outstanding academic career at Emory University where he had been a Marcus Chair of Pediatric Gastroenterology, a tenured Professor of Pediatrics and Microbiology and the Director of the Division of Pediatric Gastroenterology, Hepatology and Nutrition.

      Dr. Gold is a national leader in the pursuit of critical questions regarding the epidemiology and pathobiology of acid-related diseases in children, in particular, gastroesophageal reflux disease (GERD) and other esophageal disease (i.e. Eosinophilic Esophagitis, EoE). He has been a key organizer and participant in all of the national and trans-Atlantic, clinical practice guidelines for treatment of pediatric H. pylori infection. In addition, 2005, he established the Aerodigestive Center of Children's Healthcare of Atlanta, and has been the Director of Quality for this multidisciplinary center that now follows almost 300 fragile, medically-complex children with Aerodigestive disease. He is the co-Director of GI Care for Kids site for the Improve Care Now Quality Improvement Collaborative which follows almost 1,100 children with IBD, and, is co-investigator on multiple national pediatric inflammatory bowel disease consortia as well as the evaluation of dietary approaches (i.e. specific carbohydrate diet; SCD) in the management of pediatric IBD. He was a member of the FDA panel establishing GRAS status for Lactobacillus and Bifidobacterium probiotics, and he has been actively involved in characterizing the gut microflora and its relationship to diet and the development and management of IBD, as well as GI allergy and eosinophilic esophagitis, EoE. Dr. Gold has diligently served the North American Society for Pediatric Gastroenterology Hepatology and Nutrition (NASPGHAN) in numerous capacities including being committee chair, being elected to counsel, and most recently, received the honor of being chosen by his peers in Canada, the U.S. and Mexico as the new President-elect of NASPGHAN.

      Dr. Gold has published over 155 peer-reviewed manuscripts, over 35 book chapters, is been a sought-after lecturer on upper GI disease in children, as well as, is an international thought leader on pediatric esophageal disease (gastroesophageal reflux disease, GERD; eosinophilic esophagitis, EoE), Helicobacter pylori infection, as well as gut-microbial interactions leading to intestinal inflammation, allergy and immune-mediate disease, including pediatric inflammatory bowel disease (Crohn's and ulcerative colitis).

    Abstract

    DATE: September 19, 2019
    TIME:  8:00am PDT, 11:00am EDT

    In this webinar we will be reviewing the role of host and the microbiome in the pathobiology of IBD and provide an overview of the epidemiology of the disease in pediatric patients and why phenotyping disease is important for therapy.  We will be discussing how the fecal microbiome is complex and biologically important, ie dysbiosis in a number of diseases, in particular IBD.  We will also be reviewing the diagnostic approach to the pediatric patient with suspected IBD and the methods for assessing treatment success including the importance of fecal calprotectin in diagnosis and monitoring outcomes.  Finally we will provide a brief overview of both the pharmacological and nutritional approach to pediatric IBD treatment.

    Learning Objectives:

    • Review basic immuno-pathobiology of IBD and the phenotypes of IBD or IBDs - Crohn’s, Ulcerative Colitis and Indeterminate Colitis
    • Briefly describe the epidemiology of IBD in children
    • Describe the diagnostic testing for IBD in the pediatric patient
    • Use of fecal biomarker(s), calprotectin for diagnosis and treatment monitoring
    • Outline approaches to treatment of IBD in children; and why these approaches might work, and why fecal calprotectin is an optimal tool to assess outcomes

     

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    Loading Comments...
    Show Resources
    Attendees
    • See more